Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Christine DeCapite"'
Autor:
Subrata Sen, Ann M. Killary, Randall E. Brand, Anirban Maitra, Cristian Coarfa, Kimberly S. Kirkwood, Pamela L. Paris, Mark W. Hurd, Christine DeCapite, Gary Longton, Ying Huang, Kimal Rajapakshe, Mei Chee Tai, Suyu Liu, Rachel L. Dittmar
Supplementary Table #1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::867fd9cc4ee7be096e0b5f05339f6df1
https://doi.org/10.1158/1940-6207.22533355.v1
https://doi.org/10.1158/1940-6207.22533355.v1
Autor:
Subrata Sen, Ann M. Killary, Randall E. Brand, Anirban Maitra, Cristian Coarfa, Kimberly S. Kirkwood, Pamela L. Paris, Mark W. Hurd, Christine DeCapite, Gary Longton, Ying Huang, Kimal Rajapakshe, Mei Chee Tai, Suyu Liu, Rachel L. Dittmar
Early detection of pancreatic ductal adenocarcinoma (PDAC) is key to improving patient outcomes; however, PDAC is usually diagnosed late. Therefore, blood-based minimally invasive biomarker assays for limited volume clinical samples are urgently need
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::421c59b3ca6b058d9ed07898352f8e55
https://doi.org/10.1158/1940-6207.c.6547039.v1
https://doi.org/10.1158/1940-6207.c.6547039.v1
Autor:
Subrata Sen, Ann M. Killary, Randall E. Brand, Anirban Maitra, Cristian Coarfa, Kimberly S. Kirkwood, Pamela L. Paris, Mark W. Hurd, Christine DeCapite, Gary Longton, Ying Huang, Kimal Rajapakshe, Mei Chee Tai, Suyu Liu, Rachel L. Dittmar
Supplemental Figure #1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::104b7760e3f4a72868cffea51315ea59
https://doi.org/10.1158/1940-6207.22533361.v1
https://doi.org/10.1158/1940-6207.22533361.v1
Autor:
Kimal Rajapakshe, Mei Chee Tai, Ying Huang, Christine Decapite, Ann M. Killary, Subrata Sen, Gary Longton, Anirban Maitra, Cristian Coarfa, Mark W. Hurd, Randall E. Brand, Pamela L. Paris, Suyu Liu, Kimberly S. Kirkwood, Rachel L. Dittmar
Publikováno v:
Cancer Prev Res (Phila)
Cancer prevention research (Philadelphia, Pa.), vol 14, iss 7
Cancer prevention research (Philadelphia, Pa.), vol 14, iss 7
Early detection of pancreatic ductal adenocarcinoma (PDAC) is key to improving patient outcomes; however, PDAC is usually diagnosed late. Therefore, blood-based minimally invasive biomarker assays for limited volume clinical samples are urgently need
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1580e24a9fd20eba6aa1440cbcda1e20
https://pubmed.ncbi.nlm.nih.gov/33893071
https://pubmed.ncbi.nlm.nih.gov/33893071
Autor:
Teng-Kuei Hsu, Christine Decapite, Ofer Shapira, Alessandro Paniccia, Chun Yang, Shivani Mahajan, Richard Bourgon, Peter Ulz, Marvin Bertin, Amit Pasupathy, Julie M. Granka, Adam Drake, C. Jimmy Lin, Tzu-Yu Liu, Preet Kaur, Randall E. Brand, Kaitlyn Coil, Maggie C. Louie, Billie Gould, Hayley Donnella, Amer H. Zureikat, Eric A. Ariazi
Publikováno v:
Cancer Research. 81:PO-007
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with an overall five-year survival rate of 11%. Potential curative resection is possible if the tumor is detected at an early stage, with a five-year survival rate of 42%. The o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57b6404d6d01f5f020fa4d3d5860cf8b
https://doi.org/10.1158/1538-7445.panca21-po-007
https://doi.org/10.1158/1538-7445.panca21-po-007